title: [Treatment of chlamydial urethroadnexitis with erythromycin (author's transl)].
abstract: Chlamydia are primarily to be considered as possible pathogens in abacterial urethroadnexitis besides mycoplasma and ureaplasma. Beside these, yeasts, trichomonads and herpes viruses play a subordinate role only. Treatment with with erythromycin is promising. This is shown in the comparison of the concentrations we found by the Blenk and Blenk MIC determinations in serum, in material expressed from the prostate and in urine.
mesh_terms: D002690:Chlamydia Infections / Q000188:drug therapy*; D004917:Erythromycin / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy*; D014526:Urethritis / Q000188:drug therapy*
chemical_list: D004917:Erythromycin
vernacular_title: Behandlung von Chlamydien-Urethro-Adnexitiden mit Erythromycin.